Biopharmaceutical company InterMune Inc.(ITMN) has drawn takeover bids from suitors including Sanofi S.A.(SNYNF) , Roche Holding AG(RHHVF) , GlaxoSmithKline PLC(GSK) and Actelion Ltd.(ALIOF) , Bloomberg News reported Wednesday on its website, citing people with knowledge of the matter.
Goldman Sachs Group Inc. (GS) and Centerview Partners LLC are advising California-based InterMune(ITMN) in the process, the people told Bloomberg.
Full story at: www.bloomberg.com/news/2014-08-13/europe-s-biggest-drugmakers-said-to-bid-for-intermune.html
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM